News & Updates

Patients with oesophageal squamous cell carcinoma (ESCC) see better survival and safety outcomes after treatment with neoadjuvant chemoradiation therapy (NCRT) as compared with neoadjuvant chemotherapy (NCT) alone, according to a recent meta-analysis.

Bulevirtide at a dose of 2 mg or 10 mg daily induces biochemical and virological response in patients with chronic hepatitis D virus (HDV) infection, according to results of Study MYR301.

Concentrations of albumin and the ratio between lymphocyte and monocyte counts can predict failure of tacrolimus treatment in patients with ulcerative colitis, reports a recent study.

Treatment with warfarin appears to lead to a higher frequency of upper and major gastrointestinal (GI) bleeding as compared with direct oral anticoagulants (DOACs), a study has found.

Patients with both types of inflammatory bowel disease (IBD) are at risk of all-cause dementia risk, particularly frontotemporal dementia in Crohn’s disease patients, but this association may be attributed to frequent healthcare system contacts by patients with IBD detection bias, according to a study.

A team of scientists from Singapore has engineered probiotics that work to restore bile salt metabolism in the intestine, effectively nipping the development of Clostridioides difficile infection (CDI) in the bud.

The tumour necrosis factor-alpha (TNF-α) antagonist therapies adalimumab and infliximab are more effective than vedolizumab and ustekinumab in achieving endoscopic healing (EH) at 1 year among patients with moderate-to-severe Crohn’s disease (CD), a recent study has shown.